1. Home
  2. WST vs BNTX Comparison

WST vs BNTX Comparison

Compare WST & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo West Pharmaceutical Services Inc.

WST

West Pharmaceutical Services Inc.

HOLD

Current Price

$275.18

Market Cap

20.2B

Sector

Health Care

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$95.02

Market Cap

24.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WST
BNTX
Founded
1923
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.2B
24.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
WST
BNTX
Price
$275.18
$95.02
Analyst Decision
Strong Buy
Buy
Analyst Count
8
11
Target Price
$345.75
$137.40
AVG Volume (30 Days)
675.4K
1.4M
Earning Date
02-12-2026
11-03-2025
Dividend Yield
0.32%
N/A
EPS Growth
0.17
N/A
EPS
6.75
N/A
Revenue
$3,017,900,000.00
$3,698,814,972.00
Revenue This Year
$7.01
$2.03
Revenue Next Year
$6.20
N/A
P/E Ratio
$40.75
N/A
Revenue Growth
4.92
3.70
52 Week Low
$187.43
$81.20
52 Week High
$348.90
$129.27

Technical Indicators

Market Signals
Indicator
WST
BNTX
Relative Strength Index (RSI) 52.34 45.84
Support Level $272.53 $94.00
Resistance Level $277.75 $95.71
Average True Range (ATR) 5.66 1.74
MACD 0.56 0.52
Stochastic Oscillator 72.82 62.66

Price Performance

Historical Comparison
WST
BNTX

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: